Clinical bene fi ts of oral capecitabine over intravenous 5- fl uorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer

HIGHLIGHTS

• who: . et al. from the National Institute of Oncology (NIO), Department of Surgery, University of, Department of Oncotherapy have published the research work: Clinical bene fi ts of oral capecitabine over intravenous 5- fl uorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer, in the Journal: (JOURNAL) of 14/02/2012
• what: The study showed that regardless of fluoropyrimidine derivative administered to the patients, the results were similar. During the study , the authors not only assessed the effects of the two different neoadjuvant oncological treatments for rectal tumours, but . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.